Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mindy I Davis

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Human Molecular Genetics|June 1, 2014
Inheritance of rare functional GCKR variants and their contribution to triglyceride levels in familiesMatthew G Rees, Anne Raimondo, Jian Wang, et al.
The Journal of Biological Chemistry|March 27, 2014
Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1Mindy I Davis, Stefan Gross, Min Shen, et al.
Scientific Reports|November 25, 2016
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination ScreeningLu Chen, Kelli Wilson, Ian Goldlust, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Antiparasitic ActivityMindy I Davis, Stephen L Patrick, Walker M Blanding, et al.
Biochemical and Biophysical Research Communications|April 2, 2026
Polypharmacologic phosphoinositide modulation by FTY720 triggers endomembrane trafficking collapse and metabolic starvation in cancer cellsSatoshi Kofuji, Kazutaka Sumita, Yoshiki Ikeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing SarcomaChristine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
The Journal of Biological Chemistry|September 30, 2016
Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma ModelsMindy I Davis, Rajan Pragani, Jennifer T Fox, et al.
Biochemical and Biophysical Research Communications|May 12, 2024
A high dose KRP203 induces cytoplasmic vacuoles associated with altered phosphoinositide segregation and endosome expansionSatoshi Kofuji, Kara Wolfe, Kazutaka Sumita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing SarcomaLillian M Guenther, Neekesh V Dharia, Linda Ross, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase InhibitorsTheresa D Manz, Sindhu C Sivakumaren, Adam Yasgar, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Human Molecular Genetics|June 1, 2014
Inheritance of rare functional GCKR variants and their contribution to triglyceride levels in familiesMatthew G Rees, Anne Raimondo, Jian Wang, et al.
The Journal of Biological Chemistry|March 27, 2014
Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1Mindy I Davis, Stefan Gross, Min Shen, et al.
Scientific Reports|November 25, 2016
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination ScreeningLu Chen, Kelli Wilson, Ian Goldlust, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Antiparasitic ActivityMindy I Davis, Stephen L Patrick, Walker M Blanding, et al.
Biochemical and Biophysical Research Communications|April 2, 2026
Polypharmacologic phosphoinositide modulation by FTY720 triggers endomembrane trafficking collapse and metabolic starvation in cancer cellsSatoshi Kofuji, Kazutaka Sumita, Yoshiki Ikeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing SarcomaChristine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
The Journal of Biological Chemistry|September 30, 2016
Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma ModelsMindy I Davis, Rajan Pragani, Jennifer T Fox, et al.
Biochemical and Biophysical Research Communications|May 12, 2024
A high dose KRP203 induces cytoplasmic vacuoles associated with altered phosphoinositide segregation and endosome expansionSatoshi Kofuji, Kara Wolfe, Kazutaka Sumita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing SarcomaLillian M Guenther, Neekesh V Dharia, Linda Ross, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase InhibitorsTheresa D Manz, Sindhu C Sivakumaren, Adam Yasgar, et al.
Pageof 4